United States· US:25021-122_a980a9e1-16f8-41c8-a8e4-31101948966c
cefepime
A cefepime product containing cefepime hydrochloride, registered in United States by Sagent Pharmaceuticals. The same ATC class is registered in 17 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cefepime is registered in 17 of 19 countries.
Countries holding a registration under ATC J01DE01 (cefepime), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Cefepime · ATC J01DE01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefepime costs, country by country.
Normalised to the WHO defined daily dose (4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cefepime · price per daily dose (4 g)
USD · FX 28 Sept 2026
- ES Spain$33.20
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CEFEPIME HYDROCHLORIDE
- Manufacturer
- Sagent Pharmaceuticals
- Country
- United States (US)
- ATC code
- J01DE01
- ATC class
- Cefepime
- Defined daily dose
- 4 g, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 30, 2026
Packs & prices · 2
- ndc1125021-122-50
- ndc11250211225010 VIAL in 1 CARTON (25021-122-50) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
189 interactions on record for cefepime.
Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefepime · interactions on record
189 records
- 19 moderate
- 170 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefepime in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCEFEPIM MIPMIP Pharma GmbH, Blieskastel
- BelgiumCefepim Fresenius Kabi 2 gFresenius Kabi
- SpainCEFEPIMA ACCORD 2 g POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGAccord Healthcare S.L.U.
- PolandCefepim MIP PharmaMIP Pharma GmbH
- SwitzerlandCefepim Leman IV 2 g, poudre pour solution injectable/pour perfusionLeman SKL SA
- FinlandCefepim MIP PharmaMIP Pharma GmbH
- NorwayCefepim MIPMIP Pharma GmbH
- SwedenCefepim MIP 2 g Pulver till injektions-/infusionsvätska, lösningMIP Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Cefepim Aptapharma, Cefepim Mip
- Belgium · Cefepim Fresenius Kabi, Céfépime Ldp-Laboratorios Torlan
- Bulgaria · Алфацеф, Бактерипим
- Cyprus · Cefepim Noridem, Cefepime Aptapharma
- Czechia · Cefepim Mip, Cefepim Noridem
- Germany · Cefepim Accord, Cefepim Mip
- Denmark · Cefepim Mip
- Estonia · Alphacef, Cefepime Mip
- Spain · Cefepima Kabi, Cefepima Ldp-Laboratorios Torlan
- Finland · Cefepim Mip Pharma
- France · Cefepime Accord, Cefepime Noridem
- Greece · Anticepim, Cefepime /Kabi
- Croatia · Cefepim Aptapharma, Cefepime Kabi
- Hungary · Cefepim Aptapharma, Cefepim Noridem
- Italy · Cefepime Noridem, Cefepime Qilu
- Lithuania · Cefepime Mip, Cefepime Norameda
- Luxembourg · Cefepime Noridem
- Latvia · Cefepime Mip, Cefepime Norameda
- Malta · Cefepime Aptapharma
- Netherlands · Cefepim Fresenius Kabi, Cefepim Noridem
- Norway · Cefepim Mip
- Poland · Cefepim Mip Pharma, Cefepime Aptapharma
- Portugal · Cefepima Accord, Cefepima Basi
- Romania · Cefepimă Aptapharma, Cefepimă Mip
- Sweden · Cefepim Mip
- Slovenia · Cefepim Aptapharma, Cefepim Kabi
- Slovakia · Cefepim Mip, Cefepím Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/944d4f74-9908-4b6e-a3fd-7dbb3ef9b9c7 GET /v1/drugs/944d4f74-9908-4b6e-a3fd-7dbb3ef9b9c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "2",
"substance": "CEFEPIME HYDROCHLORIDE",
"productndc": "25021-122",
"dosage_form": "INJECTION, POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "g/1",
"application_number": "ANDA065441",
"marketing_category": "ANDA"
}See everything about cefepime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.